Mr. John Swords:

There are issues. That has been discussed. There has also been discussion around possibly purchasing drugs outside of the country and engaging in parallel trading in relation to drugs but that could work out more expensive because of the effort required, including bringing in expertise to the companies and then bringing the drugs directly into the country. We have a national distribution centre in Tullamore. Within that we have a licence for distribution. We looked at this issue in the context of what the costs would be as distinct from what the distributors charge us but they were not comparable in terms of effort and the amount of money required. Even ensuring we were getting the right drugs, in terms of ingredients, and not spurious drugs was a risk. It has been discussed. The costs are quite high so we have to look at different ways of doing that.